Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary function in patients on long-term, low-dose methotrexate.

T J Phillips, P J Wallis, D H Jones

    The British Journal of Dermatology
    |December 1, 1986
    PubMed
    Summary

    Long-term, low-dose methotrexate for psoriasis did not show signs of early lung damage in patients. This study monitored pulmonary function to assess methotrexate

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Black Hole Spectroscopy and Tests of General Relativity with GW250114.

    Physical review letters·2026
    Same author

    GW250114: Testing Hawking's Area Law and the Kerr Nature of Black Holes.

    Physical review letters·2025
    Same author

    Improving cosmological reach of a gravitational wave observatory using Deep Loop Shaping.

    Science (New York, N.Y.)·2025
    Same author

    SEPN1-related myopathies: clinical course in a large cohort of patients.

    Neurology·2011
    Same author

    Markers for the identification of tumours arising from the neuroectoderm.

    Reviews in the neurosciences·2011
    Same author

    Use of polymerase chain reaction for making recombinant constructs.

    Methods in molecular biology (Clifton, N.J.)·2011

    Area of Science:

    • Dermatology and Pulmonology
    • Pharmacology and Toxicology

    Background:

    • Psoriasis is a chronic inflammatory skin condition.
    • Methotrexate is a common treatment for moderate to severe psoriasis.
    • Concerns exist regarding potential long-term pulmonary toxicity of methotrexate.

    Observation:

    • A cohort of patients undergoing long-term, low-dose methotrexate therapy for psoriasis was evaluated.
    • Pulmonary function tests were systematically performed on study participants.

    Findings:

    • No evidence of early pulmonary damage was detected in patients receiving treatment.
    • Methotrexate, at low doses for psoriasis, appears safe for pulmonary health in the studied cohort.

    Implications:

    • This research suggests a favorable pulmonary safety profile for low-dose methotrexate in psoriasis management.
    • Further long-term studies may be warranted to confirm these findings across diverse patient populations.

    Related Experiment Videos